The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers
NCT02063282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 394
Last updated 2016-04-21
Summary
The investigators hypothesize that development of symptoms characteristic of Clostridium difficile infection will be 2-3 times higher in asymptomatic carriers, compared to that of non carriers and expect to find risk factors for development of symptomatic clostridium difficile.
Conditions
- Clostridium Difficile
- Colitis
Sponsors & Collaborators
-
Amos Yinnon
lead OTHER
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NCT05389904 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis
NCT01959048 ·Status: TERMINATED ·Phase: NA
-
Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region
NCT01560832 ·Status: COMPLETED
-
Use of Bismuth Subsalicylate in Clostridium Difficile Colitis
NCT03592082 ·Status: WITHDRAWN ·Phase: PHASE4
-
Host Immune Response to Clostridium Difficile Infection (ICD)
NCT02440438 ·Status: COMPLETED ·Phase: NA
-
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
NCT02896244 ·Status: COMPLETED
-
Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile
NCT03025672 ·Status: COMPLETED
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Reduction of C-Difficile Infection Using Stool Transplant
NCT02112279 ·Status: UNKNOWN ·Phase: PHASE1
-
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825 ·Status: RECRUITING
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
NCT02830542 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients
NCT00002062 ·Status: COMPLETED ·Phase: NA
-
Immune Response to C.Difficile Infection
NCT02797288 ·Status: UNKNOWN
-
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
NCT02326636 ·Status: COMPLETED
-
Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile
NCT05192148 ·Status: UNKNOWN ·Phase: NA
-
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
NCT07282665 ·Status: RECRUITING ·Phase: PHASE3
-
Transplantation of Fecal Microbiota for Clostridium Difficile Infection
NCT01958463 ·Status: UNKNOWN ·Phase: PHASE3
-
Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea
NCT04567134 ·Status: UNKNOWN
-
Secondary Prevention of Clostridioides Difficile Using Vancomycin
NCT06979609 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Clostridium Difficile Infection (CDI) in Hematologic Patients.
NCT03964844 ·Status: UNKNOWN
-
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
NCT02951702 ·Status: COMPLETED ·Phase: PHASE4
-
C.Difficile Observational Study
NCT06277999 ·Status: COMPLETED
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2